Accessibility Menu
 
Sera Prognostics logo

Sera Prognostics

(NASDAQ) SERA

Current Price$2.15
Market Cap$81.03M
Since IPO (2021)-83%
5 YearN/A
1 Year-40%
1 Month-7%

Sera Prognostics Financials at a Glance

Market Cap

$81.03M

Revenue (TTM)

$81.00K

Net Income (TTM)

$31.93M

EPS (TTM)

$-0.67

P/E Ratio

-3.07

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$2.15

Volume

409

Open

$2.05

Previous Close

$2.15

Daily Range

$2.05 - $2.15

52-Week Range

$1.37 - $4.09

SERA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sera Prognostics

Industry

Biotechnology

Employees

72

CEO

Evguenia Lindgardt, MBA

Headquarters

Salt Lake City, UT 84109, US

SERA Financials

Key Financial Metrics (TTM)

Gross Margin

-1%

Operating Margin

-451%

Net Income Margin

-394%

Return on Equity

-52%

Return on Capital

-47%

Return on Assets

-31%

Earnings Yield

-32.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$81.03M

Shares Outstanding

39.14M

Volume

409

Short Interest

0.00%

Avg. Volume

61.85K

Financials (TTM)

Gross Profit

$83.00K

Operating Income

$36.50M

EBITDA

$35.56M

Operating Cash Flow

$25.62M

Capital Expenditure

$726.00K

Free Cash Flow

$26.35M

Cash & ST Invst.

$39.20M

Total Debt

$2.34M

Sera Prognostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$10.00K

-58.3%

Gross Profit

$32.00K

-300.0%

Gross Margin

-3.20%

N/A

Market Cap

$81.03M

N/A

Market Cap/Employee

$1.29M

N/A

Employees

63

N/A

Net Income

$7.88M

+8.1%

EBITDA

$12.22M

-46.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$36.86M

-18.8%

Accounts Receivable

$12.00K

-64.7%

Inventory

$0.00

N/A

Long Term Debt

$2.34M

+116750.0%

Short Term Debt

$2.00K

-99.8%

Return on Assets

-31.32%

N/A

Return on Invested Capital

-46.95%

N/A

Free Cash Flow

$6.45M

-2.0%

Operating Cash Flow

$6.12M

+2.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HURATuHURA Biosciences, Inc.
$1.62-9.50%
ONCYOncolytics Biotech Inc.
$0.93+9.58%
CGTXCognition Therapeutics, Inc.
$0.89+17.37%
RPIDRapid Micro Biosystems, Inc.
$2.16-4.85%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$175.74+0.01%
NKENike
$44.73-0.15%
MUMicron Technology
$368.11+0.09%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%

Questions About SERA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.